Fosfomycin increases chromosome instability in lymphocytes from Fanconi Anemia patients
- 25 April 2013
- journal article
- research article
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 754 (1-2) , 58-62
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Reappraisal of Current Dosing Strategies for Intravenous Fosfomycin in Children and NeonatesClinical Pharmacokinetics, 2011
- Mutations of the SLX4 gene in Fanconi anemiaNature Genetics, 2011
- Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infectionsInternational Journal of Antimicrobial Agents, 2009
- Fosfomycin: an old, new friend?European Journal of Clinical Microbiology & Infectious Diseases, 2009
- Effect of superoxide dismutase and catalase on spontaneously occurring chromosome breaks in patients with Fanconi's anemiaHereditas, 2009
- Diepoxybutane activates the mitochondrial apoptotic pathway and mediates apoptosis in human lymphoblasts through oxidative stressToxicology in Vitro, 2007
- The 5‘-GNC Site for DNA Interstrand Cross-Linking Is Conserved for Diepoxybutane StereoisomersChemical Research in Toxicology, 2005
- Fosfomycin TromethamineDrugs, 1997
- The Role of Hydrolysis in the Detoxification of 1,2:3,4-Diepoxybutane by Human, Rat, and Mouse Liver and Lungin VitroToxicology and Applied Pharmacology, 1996
- Oxygen-dependence of chromosomal aberrations in Fanconi's anaemiaNature, 1981